Delivery Order SPE2DB20D2104-SPE2DB24FR50W
Award Date 12/6/23
Potential Completion Date 12/7/23
Potential Value $9.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $3,764.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of insulin aspart 100 unit/mL pens. The contract is a delivery order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $23,761.24, is for the delivery of insulin aspart 100 unit/mL pens. The contract has an ultimate completion date of January 22, 2024 and is structured as a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of insulin aspart 100 unit/mL pens. The contract has a ceiling value of $9,296.70 and a period of performance ending on January 9, 2024. This award is issued as a delivery order against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which has a maximum potential value of $999,999,999.00 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,145.34 firm-fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL vials. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a range of medical commodities to support military treatment...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,070.96 firm fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL pens. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,610.83 firm fixed-price delivery order is for the supply of INSULIN ASPART 100 UNIT/ML PEN 3ML medical products. The contract has an ultimate completion date of December 26, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL. The $22,571.91 firm fixed-price delivery order is a part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a wide range of pharmaceutical products and medical supplies for military healthcare programs. This award does...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,491.83 firm fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL Pen, 3mL, a diabetes medication. The contract has an ultimate completion date of April 18, 2025 and is not set aside for any special type of business. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,474.68 firm fixed-price delivery order is for the supply of INSULIN ASPART 100 UNIT/ML PEN 3ML, a critical medical commodity used in the treatment of diabetes. The contract has an ultimate completion date of May 1, 2024 and was awarded on April 30, 2024. This delivery order is part of a larger $999,999,999...
- This federal contract award is for insulin aspart 100 unit/mL pens, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,365.38 firm fixed-price delivery order has a completion date of May 10, 2022 and was awarded on May 9, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which operates under the "Amerisourcebergen" name. The company holds a significant $999,999,999 Indefinite...